Ritalin News and Research

RSS

Barr confirms patent challenge of Ritalin LA

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by Novartis Pharmaceuticals Corporation in connection with its Ritalin LA (methylphenidate hydrochloride) extended-release capsules, 10mg, 20mg, 30mg and 40mg.

5 Nov 2007

ADHD stimulant drug therapy helps improve long-term school outcomes

In an 18-year-study on attention-deficit hyperactivity disorder (ADHD), Mayo Clinic researchers found that treatment with prescription stimulants is associated with improved long-term academic success of children with ADHD.

18 Sep 2007

ADHD and preschoolers

Attention-deficit/hyperactivity disorder (ADHD) is no longer diagnosed just in schoolchildren.

5 Sep 2007

ADHD linked to depressed dopamine activity in the brain

Adults with attention-deficit/hyperactivity disorder (ADHD) show a blunted response to the drug methylphenidate (Ritalin), which increases brain dopamine levels, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

7 Aug 2007

ADHD drug given to toddlers

Reports in the UK suggest that almost 400,000 youngsters aged between 5 and 19 are being treated with Ritalin and similar drugs for attention deficit hyperactivity disorder, or ADHD, regardless of fears about the drugs' serious side-effects such as cardiovascular disorders, hallucinations and even suicidal thoughts.

30 Jul 2007

Parents of kids with ADHD rejoice - it will get better whatever the treatment!

A new study has welcome news for parents of children who suffer from Attention-Deficit Hyperactivity Disorder (ADHD).

21 Jul 2007

Potential dangers of Ritalin

Use of the attention deficit/hyperactivity disorder (ADHD) drug Ritalin by young children may cause long-term changes in the developing brain, suggests a new study of very young rats by a research team at Weill Cornell Medical College in New York City.

18 Jul 2007

Parents using Ritalin to get children through exams and divorce

Reports in the Chinese media say some parents are prepared to dose their offspring with powerful drugs to help them through exams.

5 Jun 2007

Modafinil (Provigil) alleviates post-chemotherapy fogginess

A drug described by some people as a genius pill for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as chemo-brain, according to a University of Rochester Medical Center study.

5 Jun 2007

Ritalin abuse is on the rise among teens

College is hard enough. But throw in end-of-semester exams, term papers and standardized tests, and there just aren't enough hours in the day. Enter Ritalin, the latest drug of choice among sleep-deprived students struggling to make the grade.

11 May 2007

FDA wants clear warnings on ADHD drugs

The Food and Drug Administration (FDA) in the United States has ordered drugmakers to alert patients to the possible cardiovascular and psychiatric risks attached to drugs used to treat attention deficit hyperactivity disorder (ADHD).

22 Feb 2007

At last the culprit in Autism is revealed

An international team of scientists have discovered two new genetic links that may predispose children to develop autism.

19 Feb 2007

Popular ADHD drug Ritalin safe and effective for pre-schoolers

A new study by researchers from the Johns Hopkins Children's Center and five other medical centers concludes that carefully measured, low doses of methylphenidate (Ritalin) are safe and effective for attention-deficit and hyperactivity disorder (ADHD) in preschoolers.

23 Oct 2006

ADHD drugs to carry warnings regarding heart problems, psychotic behavior and sudden death

According to U.S. health officials several drugs used to treat attention deficit hyperactivity disorder (ADHD) must now include new warning information about the risk of serious heart problems, psychotic behavior and sudden death.

24 Aug 2006

Almost half of kids with ADHD are not being treated

In contrast to claims that children are being overmedicated for attention-deficit/hyperactivity disorder (ADHD), a team of researchers at Washington University School of Medicine in St. Louis has found that a high percentage of kids with ADHD are not receiving treatment.

4 Aug 2006

"Magic" mushrooms create profound mystical experience and change behaviour

A group of healthy well educated volunteers appear to have achieved some sort of profound mystical experience that led to behaviour changes lasting for weeks after taking a drug derived from 'magic mushrooms'.

12 Jul 2006

Hallucinogen in mushrooms creates mystical/spiritual experiences

Using unusually rigorous scientific conditions and measures, Johns Hopkins researchers have shown that the active agent in "sacred mushrooms" can induce mystical/spiritual experiences descriptively identical to spontaneous ones people have reported for centuries.

11 Jul 2006